Aurobindo Pharma USA Inc Recall: Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx
Aurobindo Pharma USA Inc Recall: Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Aurobindo Pharma USA Inc; Product: Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobind
| Recalling firm | Aurobindo Pharma USA Inc |
|---|---|
| Product | Pantoprazole Sodium Delayed-Release Tablets USP, 40 mg Rx Only, 90 tablets per bottle, Manufactured for Aurobindo Pharma USA, Inc 2400 Route 130 North Dayton, NJ 08810, Manufactured by: Aurobindo Pharma Limited Unit-VII (SE2), Mahaboob Nagar (Dt) - 509302, India , NDC 65862-0560-90 |
| Reason for recall | Presence of Foreign Tablets/Capsules: Firm received a market complaint stating the presence of one foreign tablet (Montelukast Sodium Chewable Tab 4mg) in the product bottle of Pantoprazole. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | CA |
| Recall initiated | 20160803 |
| Recall number | D-1499-2016 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →